Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke

NCT06857487 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Qingre Huatan Formula
DRUG: Qingre Huatan Formula placebo
OTHER: Guidelines-based standard care

Sponsor

Dongzhimen Hospital, Beijing